Gimeno-Valiente, F., Castedo, B. M., BadÃa, J., Linares, J., Durendez, E., Bartolomé, M. G., Arana, J. M., Camblor, D. G., Pico, F. M., Mico, B. G., Manzaneque, V. S., Pérez-Santiago, L., Moro-Valdezate, D., Pla, V., Keränen, S. R., Montagut, C., Coma, M. I., Martínez-Ciarpaglini, C., Calon, A., Tarazona, N. (2026). ctDNA MRD combined with CODEX2 to identify high-risk colorectal cancer with potential sensitivity to immunotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15664